Literature DB >> 19412651

Nonalcoholic fatty liver is a risk factor for postprandial hyperglycemia, but not for impaired fasting glucose.

Tomoko Shiga1, Yuriko Moriyoshi, Hikaru Nagahara, Keiko Shiratori.   

Abstract

PURPOSE: The first aim of this study was to elucidate the relationship between impaired glucose tolerance (IGT) and nonalcoholic fatty liver. The second was to make a rule regarding to whom 75-g oral glucose tolerance tests (OGTTs) should be applied to identify subjects with IGT and diabetes mellitus (DM) in the annual check-up at the human dry dock.
METHODS: A total of 716 subjects who visited the Department of General Medicine of the International Medical Center of Japan from May 2001 through January 2008 for an annual check-up at the human dry dock were analyzed. We evaluated risk factors related to nonalcoholic fatty liver using multivariate logistic regression analysis and compared the difference of body mass index (BMI) and glucose level at 75-g OGTT at two different time points in subjects whose fatty change had improved or worsened.
RESULTS: Nonalcoholic fatty liver was strongly related to 2-h- and 1-h-post-challenge glucose level (P<0.0001 and P=0.018, respectively), but not fasting plasma glucose (FPG) (P=0.706). The risk factors for IGT were nonalcoholic fatty liver (P<0.05), low levels of high-density lipoprotein cholesterol (HDL-C) (P=0.026) and age (P=0.013). A clearly positive relationship was observed between the difference of BMI and 2-h-post-challenge glucose level among the subjects whose fatty change had improved or worsened (R=0.6, P=0.018).
CONCLUSIONS: Nonalcoholic fatty liver was clearly related to the 2-h- or 1-h-post-challenge glucose level, but not to FPG, in 75-g OGTT, and this IGT was corrected by body weight reduction in accordance with diminished nonalcoholic fatty liver. Thus, 75-g OGTT should be applied to subjects with nonalcoholic fatty liver to evaluate IGT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412651     DOI: 10.1007/s00535-009-0059-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia.

Authors:  Ching-Chieh Su; Kun Wang; Te-Lin Hsia; Ching-Shuen Chen; Tao-Hsin Tung
Journal:  J Clin Gastroenterol       Date:  2006-07       Impact factor: 3.062

4.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Impaired splanchnic and peripheral glucose uptake in liver cirrhosis.

Authors:  E Imano; T Kanda; Y Nakatani; M Motomura; K Arai; M Matsuhisa; Y Yamasaki; M Hori
Journal:  J Hepatol       Date:  1999-09       Impact factor: 25.083

6.  Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?

Authors:  Mehmet Sargin; Oya Uygur-Bayramiçli; Haluk Sargin; Ekrem Orbay; Ali Yayla
Journal:  J Clin Gastroenterol       Date:  2003 Nov-Dec       Impact factor: 3.062

7.  Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake.

Authors:  W P Verboeket-van de Venne; K R Westerterp; B van Hoek; G R Swart
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  5 in total

1.  Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.

Authors:  Chung-Hao Li; Yu-Tsung Chou; Wei-Chen Shen; Feng-Hwa Lu; Yi-Ching Yang; Jin-Shang Wu; Chih-Jen Chang
Journal:  J Diabetes Investig       Date:  2020-05-17       Impact factor: 4.232

2.  Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Takeshi Kurihara; Miwako Kagawa; Hiroyuki Ueda; Tomoyuki Kawaguchi; Akira Fukuya; Kaizo Kagemoto; Hironori Tanaka; Yoshifumi Kida; Tetsu Tomonari; Tatsuya Taniguchi; Koichi Okamoto; Hiroshi Miyamoto; Yasushi Sato; Masahiko Nakasono; Tetsuji Takayama
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

3.  Relationship between ultrasound backscattered statistics and the concentration of fatty droplets in livers: an animal study.

Authors:  Ming-Chih Ho; Yu-Hsin Lee; Yung-Ming Jeng; Chiung-Nien Chen; King-Jen Chang; Po-Hsiang Tsui
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

4.  Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.

Authors:  Kenichiro Enooku; Mayuko Kondo; Naoto Fujiwara; Takayoshi Sasako; Junji Shibahara; Akira Kado; Kazuya Okushin; Hidetaka Fujinaga; Takeya Tsutsumi; Ryo Nakagomi; Tatsuya Minami; Masaya Sato; Hayato Nakagawa; Yuji Kondo; Yoshinari Asaoka; Ryosuke Tateishi; Kohjiro Ueki; Hitoshi Ikeda; Haruhiko Yoshida; Kyoji Moriya; Hiroshi Yotsuyanagi; Takashi Kadowaki; Masashi Fukayama; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2018-05-10       Impact factor: 7.527

Review 5.  Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research.

Authors:  Henna-Maria Uusitupa; Pia Rasinkangas; Markus J Lehtinen; Sanna M Mäkelä; Kaisa Airaksinen; Heli Anglenius; Arthur C Ouwehand; Johanna Maukonen
Journal:  Nutrients       Date:  2020-03-25       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.